General Manager of AbbVie

Mr. Blum is the  in Israel since March 2017 and the Chairman of the Pharma Committee since April 2018.
Raphy returned to Israel in 2017 after 14 years in the US. He has extensive experience in the pharmaceutical industry, bringing significant commercial experience across a broad range of Therapy Areas in a Country organization (Israel), Regions (US, EU & Asia) as well as Global pharmaceutical markets. This includes development of the full brand life cycle, new market development, brand introductions, in-line product management, brand repositioning, and market exit.
Raphy also co-led the integration of Wyeth Oncology into the Pfizer Oncology Business unit globally.